Metastatic Soft Tissue Sarcomas After Failure On At Least One Systemic Therapy clinical trials

Explore recruiting metastatic soft tissue sarcomas after failure on at least one systemic therapy clinical trials.

Also recruiting in Europe

Metastatic Soft Tissue Sarcomas After Failure On At Least One Systemic Therapy trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Phase 1b/2 study of liposomal annamycin (l-annamycin) in patients with previously treated metastatic soft-tissue sarcomas (ANNA-SARC)

Poland

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Metastatic Soft Tissue Sarcomas After Failure On At Least One Systemic Therapy trials by city

Metastatic Soft Tissue Sarcomas After Failure On At Least One Systemic Therapy in Toronto Metastatic Soft Tissue Sarcomas After Failure On At Least One Systemic Therapy in Vancouver Metastatic Soft Tissue Sarcomas After Failure On At Least One Systemic Therapy in Montreal Metastatic Soft Tissue Sarcomas After Failure On At Least One Systemic Therapy in Calgary Metastatic Soft Tissue Sarcomas After Failure On At Least One Systemic Therapy in Edmonton Metastatic Soft Tissue Sarcomas After Failure On At Least One Systemic Therapy in Ottawa Metastatic Soft Tissue Sarcomas After Failure On At Least One Systemic Therapy in Winnipeg Metastatic Soft Tissue Sarcomas After Failure On At Least One Systemic Therapy in Quebec City Metastatic Soft Tissue Sarcomas After Failure On At Least One Systemic Therapy in Hamilton Metastatic Soft Tissue Sarcomas After Failure On At Least One Systemic Therapy in Kitchener Metastatic Soft Tissue Sarcomas After Failure On At Least One Systemic Therapy in London Metastatic Soft Tissue Sarcomas After Failure On At Least One Systemic Therapy in Halifax Metastatic Soft Tissue Sarcomas After Failure On At Least One Systemic Therapy in New York Metastatic Soft Tissue Sarcomas After Failure On At Least One Systemic Therapy in Los Angeles Metastatic Soft Tissue Sarcomas After Failure On At Least One Systemic Therapy in Chicago Metastatic Soft Tissue Sarcomas After Failure On At Least One Systemic Therapy in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease